News & Articles
Selected Filters:
5 new webinars to expand your research and knowledge
Gain insights on topics from point-of-care blood testing, cardiac troponin and biomarker discovery to clinical QC and more
Virtual Neuroscience Summit 2021: Full meeting agenda
Watch world-leading scientists online, October 5, to discover the latest tools and techniques advancing Alzheimer's research, single cell characterization, biomarker discovery and more
Degenerative eye diseases: Startup scientists devise pioneering curative treatment
How scientists at Kato Pharmaceuticals have expanded from early-stage development to biopharmaceutical production of clinical drug products
Chronic disease testing and the future of personalized medicine
Watch this on-demand webinar to explore a complete workflow for the development of targeted biomarker measurements for precision medicine
Roche receives FDA approval for first companion diagnostic to identify dMMR solid tumor patients eligible for anti-PD-1 immunotherapy
Using cancer biomarkers, the VENTANA MMR RxDx Panel helps determine which tumor patients may benefit from GSK immunotherapy
Efficient exosome isolation & purification tools
5 upcoming webinars to advance your research
Gain insights on topics from point-of-care cardiac troponin, CRISPR editing efficiency, targeted biomarker measurements for precision medicine & more
Autoantibodies: The key to early diagnosis and improved patient stratification
Sengenics CSO and inventor of the KREX™ protein folding technology, Professor Jonathan Blackburn, discusses the applications of KREX™ for the discovery of autoantibody-based companion diagnostics and early disease detection biomarkers, as well as the potential benefits in the treatment of autoimmune disease, cancer, neurological and infectious diseases and beyond
Cresset announces release of new comprehensive molecule design platform Flare V5
Ligand-based technologies integrated into Flare V5 offer a comprehensive molecule design solution for drug discovery research chemists
World-class speaker lineup announced for Virtual Neuroscience Summit 2021
Register free today to join scientists from around the world as they come together to discuss the hottest topics and latest technology solutions
Thermo Fisher Scientific and UC Davis launch center of excellence in clinical metabolomics
The center will develop new technologies and reproducible analytical techniques to support rapid, cost-effective clinical research
Protein identified as new therapeutic anti-viral target for COVID-19
The research also found the presence of detectable viral RNA in blood in COVID-19 patients is a strong predictor of mortality
SARS-CoV-2 variants: Are Ct values an unused piece of the profiling puzzle?
Infectious disease scientist Dr. Padmapriya Banada explores the potential of cycle threshold values and reveals her melt-based assay alternative
Advances in materials characterization, from graphene production and correlative imaging to transmission Raman spectroscopy
Explore cutting-edge technologies and the latest resources to support your materials characterization
9 new resources to advance your biopharmaceutical research
Explore expert webinars, free downloads, latest methods, and much more to help support biopharmaceutical research
Harnessing cutting-edge proteogenomics in the quest for novel drug targets
Discover how collaborative research between big pharma and academia is using the latest proteomics platforms to revolutionize drug discovery
CardiNor has secured NOK12 million (US$1.46M) to commercialize first secretoneurin ELISA test
The growing heart failure pandemic increases need for new innovative assays
Virtual Cancer and Immunology Research Summit 2021: Full meeting agenda
Watch world-leading scientists online, May 11-12, to discover the latest tools and techniques advancing COVID-19 research, immunotherapy development, drug screening, cancer diagnostics and more
Charles River acquires Retrogenix
Beckman Coulter offers $4/high-throughput antigen test to support U.S. government initiative to expand COVID-19 testing
The company is set to support the $12 billion expansion in COVID-19 testing as vaccinations increase